Search - tctmd.com

Displaying 341 - 360 of 535

Sort: Relevancy | Date

Presentation VIVA 2017

Is Aspirin Really a Class I Medication in Peripheral Artery Disease?

Presenter: Ehrin J. Armstrong

September 19, 2017

News Conference News VIVA 2017

Low-Dose Paclitaxel DCB Shows Long-term Durability in Treating PAD

L.A. McKeown

September 18, 2017

News Conference News VIVA 2017

ACT I: Women Reap More Long-term Benefits From Carotid Stenting vs CEA

L.A. McKeown

September 15, 2017

News Conference News ESC 2017

VIVA: Could Population-Wide Screening Trial for AAA, PAD, and Hypertension Save Lives at Low Cost?

Shelley Wood

August 28, 2017

News Opinion Editor's Corner ESC 2017

ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On

Shelley Wood

August 18, 2017

News Daily News

Registry Confirms Long-term Durability of Drug-Coated Balloon for Femoropopliteal Lesions

L.A. McKeown

August 03, 2017

News Daily News

Artificially Created Thrombus May Aid in Cases of Endovascular Perforation

L.A. McKeown

July 25, 2017

News Industry News

Ra Medical Systems Names Maurice Buchbinder, M.D., and Martin Colombatto to Board of Directors

July 12, 2017

News Daily News

3-D Ultrasound Quantifies Plaque Burden in Healthy Middle-Aged Cohort

Michael O'Riordan

July 11, 2017

News Daily News

FDA: Class I Recall for Venture Catheters

L.A. McKeown

June 21, 2017

News Daily News

CMS Lauded for Coverage Decision on Supervised Exercise Therapy for PAD

L.A. McKeown

June 08, 2017

News Industry News

FDA Grants Market Clearance to Ra Medical Systems for New Peripheral Artery Disease Treatment

June 06, 2017

News Industry News

Medtronic Enrolls First Patient in Study of IN.PACT(TM) AV Access Drug-Coated Balloon in Patients with End-Stage Renal Disease

May 25, 2017

News Daily News

Wingman35 Crossing Catheters Recalled Due to Tip Splitting, Separation

Todd Neale

May 04, 2017

News Daily News

Extended DAPT May Benefit Patients With CAD and PAD, but With Caveats

L.A. McKeown

May 03, 2017

News Daily News

Most PAD Patients ‘Dramatically Undertreated’ With Preventive Meds, Lifestyle Counseling

L.A. McKeown

May 01, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2017

Shelley Wood

March 01, 2017

News Daily News

New Laser-Based Imaging Modality in Development for Atherosclerosis Assessment

Todd Neale

February 17, 2017

News Conference News ISET 2017

Bioresorbable Scaffolds for PAD: Does the Strategy Have Legs?

Caitlin E. Cox

February 17, 2017

News Conference News ISET 2017

Targeted Delivery of Dexamethasone Combats Restenosis in Femoropopliteal Lesions: DANCE Trial

Caitlin E. Cox

February 15, 2017

Advertisement

Is Aspirin Really a Class I Medication in Peripheral Artery Disease?

Low-Dose Paclitaxel DCB Shows Long-term Durability in Treating PAD

ACT I: Women Reap More Long-term Benefits From Carotid Stenting vs CEA

VIVA: Could Population-Wide Screening Trial for AAA, PAD, and Hypertension Save Lives at Low Cost?

ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On

Registry Confirms Long-term Durability of Drug-Coated Balloon for Femoropopliteal Lesions

Artificially Created Thrombus May Aid in Cases of Endovascular Perforation

Ra Medical Systems Names Maurice Buchbinder, M.D., and Martin Colombatto to Board of Directors

3-D Ultrasound Quantifies Plaque Burden in Healthy Middle-Aged Cohort

FDA: Class I Recall for Venture Catheters

CMS Lauded for Coverage Decision on Supervised Exercise Therapy for PAD

FDA Grants Market Clearance to Ra Medical Systems for New Peripheral Artery Disease Treatment

Medtronic Enrolls First Patient in Study of IN.PACT(TM) AV Access Drug-Coated Balloon in Patients with End-Stage Renal Disease

Wingman35 Crossing Catheters Recalled Due to Tip Splitting, Separation

Extended DAPT May Benefit Patients With CAD and PAD, but With Caveats

Most PAD Patients ‘Dramatically Undertreated’ With Preventive Meds, Lifestyle Counseling

TCTMD’s Top 10 Most Popular Stories for February 2017

New Laser-Based Imaging Modality in Development for Atherosclerosis Assessment

Bioresorbable Scaffolds for PAD: Does the Strategy Have Legs?

Targeted Delivery of Dexamethasone Combats Restenosis in Femoropopliteal Lesions: DANCE Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content